Compare ESNT & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ESNT | BCPC |
|---|---|---|
| Founded | 2008 | 1967 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Major Chemicals |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.6B |
| IPO Year | 2013 | 1995 |
| Metric | ESNT | BCPC |
|---|---|---|
| Price | $57.94 | $156.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | $67.29 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 632.7K | 136.7K |
| Earning Date | 05-08-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.19% | 0.55% |
| EPS Growth | 0.73 | ★ 20.87 |
| EPS | ★ 1.82 | 1.25 |
| Revenue | ★ $1,260,935,000.00 | $799,023,000.00 |
| Revenue This Year | $1.12 | $8.47 |
| Revenue Next Year | $3.37 | $4.89 |
| P/E Ratio | ★ $32.07 | $128.00 |
| Revenue Growth | 1.45 | ★ 13.56 |
| 52 Week Low | $55.22 | $139.17 |
| 52 Week High | $67.09 | $183.90 |
| Indicator | ESNT | BCPC |
|---|---|---|
| Relative Strength Index (RSI) | 37.60 | 31.95 |
| Support Level | $56.70 | $152.28 |
| Resistance Level | $61.98 | $159.54 |
| Average True Range (ATR) | 1.34 | 3.12 |
| MACD | -0.37 | 0.19 |
| Stochastic Oscillator | 2.99 | 6.64 |
Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products, title insurance, and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.